Beijing Scitop Bio-tech Co., Ltd. Stock

Equities

300858

CNE100004181

Food Processing

End-of-day quote Shenzhen S.E. 06:00:00 2024-05-08 pm EDT 5-day change 1st Jan Change
17.2 CNY +0.12% Intraday chart for Beijing Scitop Bio-tech Co., Ltd. +1.90% -10.88%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
Sales 2024 * 403M 55.79M Sales 2025 * 504M 69.77M Capitalization 4.53B 627M
Net income 2024 * 123M 17.03M Net income 2025 * 166M 22.98M EV / Sales 2024 * 11.2 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 8.99 x
P/E ratio 2024 *
36.6 x
P/E ratio 2025 *
27.3 x
Employees 263
Yield 2024 *
1.22%
Yield 2025 *
1.57%
Free-Float 42.98%
More Fundamentals * Assessed data
Dynamic Chart
Beijing Scitop Bio-Tech Co., Ltd. Proposes Final Dividend for the Year 2023 CI
Beijing Scitop Bio-tech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Beijing Scitop Bio-tech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Beijing Scitop Bio-tech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Beijing Scitop Bio-tech Co., Ltd.(XSEC:300858) added to S&P Global BMI Index CI
Lin Wei signed a Share Transfer Agreement to acquire a 6.39% stake in Beijing Scitop Bio-tech Co., Ltd. from Sun Tiansong for approximately CNY 220 million. CI
Beijing Scitop Bio-tech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Certain A Shares of Beijing Scitop Bio-tech Co., Ltd. are subject to a Lock-Up Agreement Ending on 27-JUL-2023. CI
Scitop Bio-tech Gets Patents for Four Biotechnology Inventions MT
Beijing Scitop Bio-Tech Co., Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 30 June 2023 CI
Chinese Companies to Boost Research to Better Penetrate Probiotics Sector MT
Beijing Scitop Bio-Tech Co., Ltd. Elects Liu Huiyu, Lu Fei and Fang Fang as Independent Directors CI
Beijing Scitop Bio-Tech Co., Ltd. Approves Cash Dividend for 2022 CI
Beijing Scitop Bio-Tech Co., Ltd. Announces the Profit Distribution Proposal for 2022 CI
Beijing Scitop Bio-tech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
More news
1 day-0.06%
1 week+1.78%
Current month+1.78%
1 month-3.86%
3 months+1.66%
6 months-16.72%
Current year-10.98%
More quotes
1 week
16.71
Extreme 16.71
17.40
1 month
13.81
Extreme 13.81
18.08
Current year
13.81
Extreme 13.81
19.88
1 year
13.81
Extreme 13.81
21.41
3 years
13.81
Extreme 13.81
32.99
5 years
11.59
Extreme 11.5852
38.20
10 years
11.59
Extreme 11.5852
38.20
More quotes
Managers TitleAgeSince
Chief Executive Officer 43 -
Director of Finance/CFO 60 -
Chairman 56 -
Members of the board TitleAgeSince
Director/Board Member 61 16-12-15
Chairman 56 -
Chief Executive Officer 43 -
More insiders
Date Price Change Volume
24-05-08 17.2 +0.12% 2 671 230
24-05-08 17.18 -0.06% 2,268,900
24-05-07 17.19 -0.29% 2,664,330
24-05-06 17.24 +2.13% 4,037,840
24-04-30 16.88 +3.18% 3,681,710

End-of-day quote Shenzhen S.E., May 07, 2024

More quotes
Beijing Scitop Bio-tech Co Ltd is a China-based company mainly engaged in the research, development, production and sales of compound food additives, edible probiotic products and animal and plant microecological preparations. The Company's main products include compound food additives, edible probiotic products, animal and plant microecological preparations and others. The Company mainly conducts its businesses within the China market.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
17.18 CNY
Average target price
17.67 CNY
Spread / Average Target
+2.85%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300858 Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW